UCLA Santa Monica Cardiology — Los Angeles, California

UCLA Santa Monica Cardiology is a clinical research site located in Los Angeles, California, United States 90404.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Santa Monica Cardiology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Santa Monica Cardiology?

UCLA Santa Monica Cardiology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Santa Monica Cardiology conducted?

UCLA Santa Monica Cardiology has 1 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma.

Is UCLA Santa Monica Cardiology accredited by Crixeo Health?

UCLA Santa Monica Cardiology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Santa Monica Cardiology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.